Yvonne L. Giwercman
Malmoe, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Response: Commentary: FSH receptor N680S genotype-guided choice of gonadotropin increases cumulative pregnancy and live birth rate after in vitro fertilization.
Journal: Frontiers in endocrinology
Published: March 17, 2026
Risk of non-reproductive cancer in men from couples conceiving through assisted reproduction: a Swedish nation-based register study.
Journal: European journal of epidemiology
Published: July 10, 2025
FSH receptor N680S genotype-guided gonadotropin choice increases cumulative pregnancy and live birth rates after in vitro fertilization.
Journal: Frontiers in endocrinology
Published: February 13, 2025
Non-reproductive effects of follicle-stimulating hormone in young men.
Journal: Andrology
Published: July 15, 2022
Increased risk for prostate cancer related mortality among childless men in a population-based cohort followed for up to 40 years.
Journal: Scandinavian journal of urology
Published: February 22, 2021
Testosterone replacement therapy in men who conceived with intracytoplasmic sperm injection: nationwide register study.
Journal: European journal of endocrinology
Published: September 16, 2019
The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.
Journal: Pharmacogenetics and genomics
Published: March 05, 2019
Male reproductive health statement (XIIIth international symposium on Spermatology, may 9th-12th 2018, Stockholm, Sweden.
Journal: Basic and clinical andrology
Published: October 02, 2018
High risk of hypogonadism in young male cancer survivors.
Journal: Clinical endocrinology
Published: May 29, 2017
Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment.
Journal: Asian journal of andrology
Published: November 23, 2016
Last Updated: 09/26/2026